Position in PBYI
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,244,391
-$6,470 QoQ
Shares Held
351,235
-7.2% QoQ
Ownership
0.690%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
19 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in PBYI Over Time
Shares Held
Position Value (USD)
Derivatives in PBYI
reported options exposure · as of Dec 31, 2020CallValue
$0
CallShares
0
PutValue
$290,358
PutShares
28,300
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026D. E. Shaw & Co., Inc. holds $4,328,350,520 across 180 Biotechnology names. PBYI ranks #111 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
5,625,825 | $919,934,903 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,059,062 | $350,411,843 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
2,545,486 | $189,027,789 | |
| 4 | PCVX |
Vaxcyte, Inc.
|
2,865,318 | $166,503,628 | |
| 5 | EXEL |
Exelixis, Inc.
|
3,603,063 | $154,535,371 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
1,868,708 | $120,774,597 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
1,640,381 | $111,759,157 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
248,960 | $111,170,598 |
All Filings in PBYI
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,244,391 | 351,235 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,250,861 | 378,296 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,647,555 | 498,598 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $2,197,875 | 640,780 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,692,128 | 571,665 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $678,954 | 222,608 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $146,339 | 57,388 | Shares | Defined | 2024-11-14 | |
| 2022-12-31 | $559,138 | 132,184 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,276,349 | 538,544 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,736,204 | 960,072 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $2,897,230 | 1,005,983 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,237,324 | 735,962 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $352,406 | 50,272 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,023,625 | 111,506 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $779,505 | 80,196 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $357,140 | 34,809 | Shares | Defined | 2021-02-16 | |
| 2020-12-31 | $290,358 | 28,300 | Put | Defined | 2021-02-16 | |
| 2020-09-30 | $285,547 | 28,300 | Put | Defined | 2020-11-16 | |
| 2020-09-30 | $304,888 | 30,217 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $1,981,814 | 190,011 | Shares | Defined | 2020-08-14 | |
| 2020-06-30 | $295,169 | 28,300 | Put | Defined | 2020-08-14 | |
| 2020-03-31 | $1,317,424 | 156,093 | Shares | Defined | 2020-05-15 | |
| 2020-03-31 | $238,852 | 28,300 | Put | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||